In September, Agilent completed its acquisition of Biovectra, a contract development and manufacturing organization. Now, President Trump has threatened Canada with tariffs.
President Trump on Saturday imposed tariffs on imports from Canada, China, and Mexico. On Monday, Trump said he would pause the levies on Canada and Mexico.
CEO Alberto Santagostino, who took the helm in November 2024, is looking to differentiate the Seattle-based company from other CDMOs targeting the biopharma industry.
The CDMO is building identical large-scale production facilities in the U.S. and Europe, designed to modularly and seamlessly integrate manufacturing regardless of location.
Donald Trump’s presidency is creating a sense of optimism in the sector, as he looks to implement an America First trade agenda including tariffs on China, Canada and Mexico.
CEO Wolfgang Wienand touted the divestiture at last week’s J.P. Morgan Healthcare Conference in San Francisco. However, some in the audience expressed concerns.
As CDMOs attend the J.P. Morgan Healthcare Conference in San Francisco, Jan. 13-16, analysts remain cautiously optimistic about the industry’s outlook in 2025.
President Trump’s proposed tariffs on Canada, China, and Mexico may delay new investments until policies become clearer, according to data analytics firm GlobalData.
CEO David Ricks in a Thursday earnings call touted the $23 billion that Lilly has spent on expanding its manufacturing capabilities to meet growing GLP-1 demand.
As the life sciences sector evolves with personalized medicine, biologics, and digitalization, manufacturers must innovate, invest in advanced tech, and adopt agile manufacturing...
AI and digital tools are vital in pharmaceutical manufacturing. Shiftconnector's AI platform improves efficiency, ensures compliance, and empowers teams with real-time insights...
While an effective disinfectant, the corrosive properties of chloramines can affect the performance and longevity of water treatment equipment. UV offers both economic and physical...
Improve bioreactor performance, accelerate process development from benchtop to production, assess respiratory efficiency with continuous CO2 monitoring, eliminate potential interferenc...
